Prospective Multicenter Evaluation of a Novel Low‐Axial‐Force Colonic Stent for Malignant Colorectal Obstruction
DEN Open · 2027-04 · 7 (1)
DOI: 10.1002/deo2.70466 ↗Kurz gefasst
Fachartikel in der Zeitschrift DEN Open, online erschienen am 09.11.2026. Verfasst von Ryo Otsuka und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Surgery, Gastrointestinal Center Yokohama Shin-Midori General Hospital Kanagawa Japan. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Self‐expandable metal stents (SEMSs) are used as a bridge to surgery (BTS) or for palliation (PAL) in malignant colorectal obstruction, but high axial force may contribute to perforation. We prospectively evaluated the efficacy and safety of the low‐axial‐force Naturfit colonic stent in both settings.
Methods
This prospective multicenter single‐arm study enrolled 208 patients at 11 Japanese institutions between 2019 and 2022 (BTS, n = 137; PAL, n = 71). The primary endpoint was clinical success of colorectal stenting; secondary endpoints included technical success, adverse events, surgical outcomes after BTS stenting, and 12‐month palliative outcomes.
Results
Technical success and clinical success of colorectal stenting were both 99.0%, with perforation in three patients (1.4%). In the BTS cohort, clinical success of BTS was 97.1%; no perforations occurred, and early and late adverse‐event rates were 1.5% and 3.7%. All patients underwent elective surgery; colostomy and laparoscopic surgery rates were 4.4% and 87.6%. In the palliative cohort, clinical success of colorectal stenting was 98.6%, late adverse events occurred in 16.9%, and 12‐month overall survival and stent patency were 46.6% and 67.6%.
Conclusions
Naturfit achieved high technical and clinical success of colorectal stenting with a low perforation rate. These findings support its feasibility for malignant colorectal obstruction in both BTS and palliative settings, although comparative studies are needed to determine relative advantages over other SEMSs. Trial Registration University Hospital Medical Information Network Clinical Trial Registry: UMIN000035224
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Surgery, Gastrointestinal Center Yokohama Shin-Midori General Hospital Kanagawa Japan.
- Department of Gastroenterology Tane General Hospital Osaka Japan.
- Department of Gastroenterology and Oncology Aomori Prefectural Central Hospital Aomori Japan.
- Department of Gastroenterology Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital Tokyo Japan.
- Department of Surgery Kawasaki Saiwai Hospital Kanagawa Japan.
- Department of Gastroenterology National Hospital Organization, Kure Medical Center and Chugoku Cancer Center Hiroshima Japan.
ORCID-Profile: Shuji Saito, Toshio Kuwai, Shungo Endo, Hiroyuki Isayama
Zitieren
APA
Otsuka, R., Saito, S., Fujimoto, N., Hanabata, N., Takao, A., Narita, K., Kuwai, T., Endo, S., Omori, J., Enomoto, T., Yamamoto, R., Sasaki, Y., Saida, Y., & Isayama, H. (2027). Prospective Multicenter Evaluation of a Novel Low‐Axial‐Force Colonic Stent for Malignant Colorectal Obstruction. DEN Open, 7(1). https://doi.org/10.1002/deo2.70466
Vancouver
Otsuka R, Saito S, Fujimoto N, Hanabata N, Takao A, Narita K, et al. Prospective Multicenter Evaluation of a Novel Low‐Axial‐Force Colonic Stent for Malignant Colorectal Obstruction. DEN Open. 2027;7(1). doi:10.1002/deo2.70466
BibTeX
@article{Otsuka2027,
author = {Otsuka, Ryo and Saito, Shuji and Fujimoto, Naoki and Hanabata, Norihiro and Takao, Akinari and Narita, Kazuhiro and Kuwai, Toshio and Endo, Shungo and Omori, Jun and Enomoto, Toshiyuki and Yamamoto, Ryuichi and Sasaki, Yoshihiro and Saida, Yoshihisa and Isayama, Hiroyuki},
title = {Prospective Multicenter Evaluation of a Novel Low‐Axial‐Force Colonic Stent for Malignant Colorectal Obstruction},
journal = {DEN Open},
year = {2027},
volume = {7},
number = {1},
doi = {10.1002/deo2.70466}
}
EUVIMED